Ohio’s medical cannabis market is expected to reach $520 million this year, according to cannabis industry intelligence firm BDSA, which also anticipates the state’s combined cannabis market will total $820 million in 2025 – the anticipated first year of adult-use sales after voters approved the reforms on Tuesday.
BDSA estimates that by 2027, combined cannabis sales in Ohio will reach $1.65 billion, making the state’s cannabis market “one of the fastest growing” in the U.S. In 2022, Ohio saw a 26% sales growth in medical cannabis sales, the firm said.
In a statement, Roy Bingham, co-founder and CEO of BDSA, said that “In recent years, the Midwest has become a thriving hub for the cannabis industry and Ohio is rapidly emerging as a promising market.”
“Ohio’s unique regulatory environment and the increasing acceptance of medical cannabis underline the significance of this market,” he said.
According to BDSA, in Q2 2023, flower held a 51% market share in Ohio’s medical cannabis space, with vape products holding a 23% market share. Concentrates accounted for 4% of sales, which BDSA notes is half of the 8% market share concentrates holds in other medical-only cannabis states.
Get daily cannabis business news updates. Subscribe
Thanks for reading our latest news article. Stay up to date on the latest hemp news, sourced and approved by HempRevs. If you have any questions or comments, please feel free to leave us a message in the comments!
Sign up for our weekly newsletter to stay up to date on the latest Industry news and keep a look out for our next story!
Source Disclaimer: This article was was sourced from Ganjapreneur.com (the Original Publisher). In order to maintain the functionality, trust, and safety of HempRevs.com, the content sourced from the Original Publisher may have been altered. Read the original article here:
BDSA: Ohio Medical Cannabis Market on Pace to Total $520M This Year
